Parilman & Associates

New U.S. Food and Drug Administration (FDA) regulations imposed upon the controversial diabetes drug Avandia will prohibit local retail pharmacies to carry the medication due to a confirmed risk for heart attack and other cardiovascular complications.

This motion applies to three anti-diabetes drugs manufactured by GlaxoSmithKline, Avandia, Avandamet and Avandaryl, that contain rosiglitazone - a drug that increases sensitivity to insulin and removes extra glucose from blood.

A new study titled “Bisphosphonate Use and Atypical Fractures of the Femoral Shaft” published in the May 2011 issue of the New England Journal of Medicines further strengthens the claim that bisphosphonates, like Fosamax, may increase the risk of atypical thigh bone breaks. This is the 4^th study from the publication which favorably promotes the mounting litigation against the drug’s manufacturer Merck for allegedly producing a defective and harmful drug, ultimately providing Parilman Fosamax Femur Fracture lawyers with more fuel to obtain justice for patients harmed by defective drugs.

A new study titled “Bisphosphonate Use and Atypical Fractures of the Femoral Shaft” published in the May 2011 issue of the New England Journal of Medicines further strengthens the claim that bisphosphonates, like Fosamax, may increase the risk of atypical thigh bone breaks. This is the 4^th study from the publication which favorably promotes the mounting litigation against the drug’s manufacturer Merck for allegedly producing a defective and harmful drug, ultimately providing Parilman Fosamax Femur Fracture lawyers with more fuel to obtain justice for patients harmed by defective drugs.

Acetaminophen, the generic of Tylenol, is one of the most commonly used medications throughout the entire world. Now new research published by the Journal of Clinical Oncology suggests if you take the medication regularly your health could be at risk. Frequent and long-term acetaminophen users may have and increased risk of blood cancer, and this isn’t the first time the drug is under FDA scrutiny.

Researchers from the University of Washington gathered data from approximately 65,000 men and women participants, ranging from 50-76 years old. They determined that by 2008, participants who took acetaminophen for at least four days per week for four years were twice as likely to develop some form of blood cancer.

Toyota and recalls are beginning to go together like Bonnie and Clyde. This time Toyota has recalled approximately 2.2 million vehicles to fix problems that could cause their autos to speed out of control.The massive recall is to replace vehicle floor mats that could attach to the accelerator, causing the pedals to stick in the full open position. The majority of affected vehicles are being added to a floor mat recall that was initiated in September 2009. Since then the car-maker has recalled more than 12 million cars throughout the entire world just for floor-mat interferences.

Three months ago, pharmaceutical maker GlaxoSmithKline agreed to pay $750 million to resolve a U.S. government false-claims lawsuit over charges that the company knowingly manufactured and sold adulterated drugs.The affected medications involved in the suit included the popular antidepressant Paxil and the type II diabetes medication Avandia.

This week, the whistleblower responsible for bringing to light the disturbing problems at a Glaxo plant that resulted in the false-claims lawsuit, spoke out for the first time on 60 minutes.In her interview, Cheryl Eckard, former Glaxo global quality assurance manager, made public the shocking disregard shown by the company for the safety and quality of the products they manufacture.

DePuy Orthopaedics, the subsidiary of Johnson & Johnson, has been coping with an ominous black cloud ever since the recall of its ASR hip replacement system in August 2010. Now, a DePuy Pinnacle recall seems imminent after medical warnings report that these metal-on-metal devices have abnormally high failure rates among patients. So as the storm rolls in, DePuy can only wait patiently while the flood of litigation pends on the horizon.